Although molecular subtype-based stratification and genomic signatures of increasing complexity are becoming a new strategy to guide therapeutic decisions in stage II/III colon cancer, several prognostic factors that can be easily obtained from FFPE specimens should be considered in order to create combined models that better define individual patients needs
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader https://ift.tt/2HPPwPm
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου